Blueprint Medicines Total Non-Operating Income/Expense 2014-2024 | BPMC
Blueprint Medicines total non-operating income/expense for the twelve months ending December 31, 2024 was $0.146B, a 840.57% decline year-over-year.
- Blueprint Medicines annual total non-operating income/expense for 2024 was $0.146B, a 840.57% decline from 2023.
- Blueprint Medicines annual total non-operating income/expense for 2023 was $-0.02B, a 33.71% increase from 2022.
- Blueprint Medicines annual total non-operating income/expense for 2022 was $-0.015B, a 1745.82% decline from 2021.